360 related articles for article (PubMed ID: 34077894)
1. Lutein attenuates angiotensin II- induced cardiac remodeling by inhibiting AP-1/IL-11 signaling.
Chen Y; Wang L; Huang S; Ke J; Wang Q; Zhou Z; Chang W
Redox Biol; 2021 Aug; 44():102020. PubMed ID: 34077894
[TBL] [Abstract][Full Text] [Related]
2. Oleic Acid Attenuates Ang II (Angiotensin II)-Induced Cardiac Remodeling by Inhibiting FGF23 (Fibroblast Growth Factor 23) Expression in Mice.
Liu T; Wen H; Li H; Xu H; Xiao N; Liu R; Chen L; Sun Y; Song L; Bai C; Ge J; Zhang Y; Chen J
Hypertension; 2020 Mar; 75(3):680-692. PubMed ID: 31928110
[TBL] [Abstract][Full Text] [Related]
3. Human Endomyocardial Biopsy Specimen-Derived Stromal Cells Modulate Angiotensin II-Induced Cardiac Remodeling.
Miteva K; Van Linthout S; Pappritz K; Müller I; Spillmann F; Haag M; Stachelscheid H; Ringe J; Sittinger M; Tschöpe C
Stem Cells Transl Med; 2016 Dec; 5(12):1707-1718. PubMed ID: 27460853
[TBL] [Abstract][Full Text] [Related]
4. Rhein attenuates angiotensin II-induced cardiac remodeling by modulating AMPK-FGF23 signaling.
Lu W; Zhu H; Wu J; Liao S; Cheng G; Li X
J Transl Med; 2022 Jul; 20(1):305. PubMed ID: 35794561
[TBL] [Abstract][Full Text] [Related]
5. Mep1a contributes to Ang II-induced cardiac remodeling by promoting cardiac hypertrophy, fibrosis and inflammation.
Ge W; Hou C; Zhang W; Guo X; Gao P; Song X; Gao R; Liu Y; Guo W; Li B; Zhao H; Wang J
J Mol Cell Cardiol; 2021 Mar; 152():52-68. PubMed ID: 33301800
[TBL] [Abstract][Full Text] [Related]
6. Kaempferol Alleviates Angiotensin II-Induced Cardiac Dysfunction and Interstitial Fibrosis in Mice.
Liu Y; Gao L; Guo S; Liu Y; Zhao X; Li R; Yan X; Li Y; Wang S; Niu X; Yao L; Zhang Y; Li L; Yang H
Cell Physiol Biochem; 2017; 43(6):2253-2263. PubMed ID: 29073623
[TBL] [Abstract][Full Text] [Related]
7. LongShengZhi alleviated cardiac remodeling via upregulation microRNA-150-5p with matrix metalloproteinase 14 as the target.
Gu Y; Zhang S; Chen X; Li Y; Liu Y
J Ethnopharmacol; 2022 Jun; 291():115156. PubMed ID: 35245628
[TBL] [Abstract][Full Text] [Related]
8. Apoptosis signal-regulating kinase 1 plays a pivotal role in angiotensin II-induced cardiac hypertrophy and remodeling.
Izumiya Y; Kim S; Izumi Y; Yoshida K; Yoshiyama M; Matsuzawa A; Ichijo H; Iwao H
Circ Res; 2003 Oct; 93(9):874-83. PubMed ID: 14551246
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of miR-128 Ameliorates Ang II-Induced Cardiac Remodeling via SIRT1/PIK3R1 Multiple Targets.
Zhan H; Huang F; Niu Q; Jiao M; Han X; Zhang K; Ma W; Mi S; Guo S; Zhao Z
Oxid Med Cell Longev; 2021; 2021():8889195. PubMed ID: 34646427
[TBL] [Abstract][Full Text] [Related]
10. Biochanin A inhibits cardiac hypertrophy and fibrosis in vivo and in vitro.
Feng Z; Zhang N; Bai J; Lin QY; Xie Y; Xia YL
Biomed Pharmacother; 2024 Jan; 170():116002. PubMed ID: 38091641
[TBL] [Abstract][Full Text] [Related]
11. Vaspin Ameliorates Cardiac Remodeling by Suppressing Phosphoinositide 3-Kinase/Protein Kinase B Pathway to Improve Oxidative Stress in Heart Failure Rats.
Ji M; Li Y; Liu Y; Ma G
J Cardiovasc Pharmacol; 2022 Sep; 80(3):442-452. PubMed ID: 36067399
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin-converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis, and cardiac dysfunction.
Zhong J; Basu R; Guo D; Chow FL; Byrns S; Schuster M; Loibner H; Wang XH; Penninger JM; Kassiri Z; Oudit GY
Circulation; 2010 Aug; 122(7):717-28, 18 p following 728. PubMed ID: 20679547
[TBL] [Abstract][Full Text] [Related]
13. Tabersonine attenuates Angiotensin II-induced cardiac remodeling and dysfunction through targeting TAK1 and inhibiting TAK1-mediated cardiac inflammation.
Dai C; Luo W; Chen Y; Shen S; Wang Z; Chen R; Wang J; Chattipakorn N; Huang W; Liang G
Phytomedicine; 2022 Aug; 103():154238. PubMed ID: 35696800
[TBL] [Abstract][Full Text] [Related]
14. Klotho inhibits angiotensin II-induced cardiac hypertrophy, fibrosis, and dysfunction in mice through suppression of transforming growth factor-β1 signaling pathway.
Ding J; Tang Q; Luo B; Zhang L; Lin L; Han L; Hao M; Li M; Yu L; Li M
Eur J Pharmacol; 2019 Sep; 859():172549. PubMed ID: 31325434
[TBL] [Abstract][Full Text] [Related]
15. Vinpocetine Attenuates Pathological Cardiac Remodeling by Inhibiting Cardiac Hypertrophy and Fibrosis.
Wu MP; Zhang YS; Xu X; Zhou Q; Li JD; Yan C
Cardiovasc Drugs Ther; 2017 Apr; 31(2):157-166. PubMed ID: 28321644
[TBL] [Abstract][Full Text] [Related]
16. SIRT2 Acts as a Cardioprotective Deacetylase in Pathological Cardiac Hypertrophy.
Tang X; Chen XF; Wang NY; Wang XM; Liang ST; Zheng W; Lu YB; Zhao X; Hao DL; Zhang ZQ; Zou MH; Liu DP; Chen HZ
Circulation; 2017 Nov; 136(21):2051-2067. PubMed ID: 28947430
[TBL] [Abstract][Full Text] [Related]
17. Fibroblast growth factor 12 attenuated cardiac remodeling via suppressing oxidative stress.
Liu A; Zhang Y; Xun S; Zhou G; Lin L; Mei Y
Peptides; 2022 Jul; 153():170786. PubMed ID: 35304156
[TBL] [Abstract][Full Text] [Related]
18. Sclareol attenuates angiotensin II-induced cardiac remodeling and inflammation via inhibiting MAPK signaling.
Yang N; Zou C; Luo W; Xu D; Wang M; Wang Y; Wu G; Shan P; Liang G
Phytother Res; 2023 Feb; 37(2):578-591. PubMed ID: 36178264
[TBL] [Abstract][Full Text] [Related]
19. The association between microRNA-21 and hypertension-induced cardiac remodeling.
Watanabe K; Narumi T; Watanabe T; Otaki Y; Takahashi T; Aono T; Goto J; Toshima T; Sugai T; Wanezaki M; Kutsuzawa D; Kato S; Tamura H; Nishiyama S; Takahashi H; Arimoto T; Shishido T; Watanabe M
PLoS One; 2020; 15(2):e0226053. PubMed ID: 32040481
[TBL] [Abstract][Full Text] [Related]
20. Secreted frizzled-related protein 3 alleviated cardiac remodeling induced by angiotensin II via inhibiting oxidative stress and apoptosis in mice.
Gu Y; Ding Y; Zhang X; Li Y; Shang Z
Eur J Pharmacol; 2022 Nov; 934():175303. PubMed ID: 36174667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
